Pharma Spent Record Amount on Lobbying in 2022; PBMs Are Now in Spotlight

The pharmaceutical and health products industry poured over a record amount — more than $373.7 million — into lobbying and outspent all other industries in 2022, according to data compiled by OpenSecrets.

During the 2021-2022 election cycle, the pharma/health products industry bucked its historical trend of favoring Republicans and distributed around 60% of donated campaign funds to Democratic lawmakers. Among the 20 lawmakers who received the most contributions from the industry during the election cycle, 14 are Democrats. Sen. Raphael Warnock (D-Ga.) topped the list, receiving over $764,000.

© 2023 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

us-capitol
February 24

Pharma Industry Spent Big to Block Drug Price Reform in 2021

READ MORE
pills-and-capsules-in-a-bottle-on-us-dollars-bills
September 23

Pharma Industry Braces as Dems Hash Out Drug Price Package

Read More
businessmen-shaking-hands
November 18

Payer Lobbying May Pale Next to Pharma, but Experts Say Industry Still Packs Clout

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today